| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $268.3M | — | +60.9% |
| R&D Expense | $77.0M | — | -10.9% |
| SG&A Expense | $124.3M | — | -3.9% |
| Operating Income | $26.5M | — | +131.8% |
| Pre-tax Income | $19.2M | — | +120.8% |
| Income Tax | $496K | — | +45.5% |
| Net Income | $18.7M | — | +120.2% |
| EPS (Basic) | $0.15 | — | +120.3% |
| EPS (Diluted) | $0.15 | — | +120.3% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $405.2M | -13.1% | +13.1% |
| Accounts Receivable | $440.3M | +20.2% | +87.2% |
| Inventory | $131.4M | -7.8% | +59.3% |
| Current Assets | $1.03B | +1.3% | +41.3% |
| Total Assets | $1.08B | +0.7% | +34.1% |
| Current Liabilities | $283.4M |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$61.0M | — | -14.1% |
| Capital Expenditures | $8K | — | +0.0% |
| Investing Cash Flow | -$8K | — | +0.0% |
| Financing Cash Flow | $64K | — | -76.6% |
| Free Cash Flow | -$61.0M | — | -14.1% |
| +58.9% |
| Total Liabilities | $667.6M | -5.3% | +3.8% |
| Stockholders' Equity | $414.9M | +12.1% | +152.7% |